Business Context and Reporting Period
Company: Minerva Neurosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 2, 2017
Event: Entry into a Material Definitive Agreement (Office Sublease)
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or liquidity metrics. The report focuses exclusively on a specific contractual agreement.
Material Changes and Agreement Details
On October 2, 2017, the Company entered into a sublease agreement with Profitect, Inc. for approximately 5,923 rentable square feet at 1601 Trapelo Road, Waltham, MA.
- Term: November 1, 2017 to July 30, 2021.
- Rental Rate: Starts at $14,807.50 per month, escalating to a maximum of $16,288.25 per month in the final 12 months.
- Incentives: The Sublandlord provided the first two months of the term free of charge.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks beyond the standard qualification that the summary is subject to the full text of the Sublease Agreement filed as Exhibit 10.1.
Investor Verification Checklist
- Review the full text of the Sublease Agreement (Exhibit 10.1) for additional covenants or termination rights not summarized in the 8-K.
- Verify the impact of the new monthly lease obligation on the Company's future cash burn rate, given the Company's pre-revenue status typical of clinical-stage biopharmaceutical firms.
- Confirm the Company's total available cash and runway relative to the new fixed operating expense starting November 2017.